サマリー

米国の臨床試験市場 2023-2027
米国の臨床試験市場は2022-2027年に59億米ドル成長し、予測期間中のCAGRは5.3%で加速すると予測される。当レポートでは、米国の臨床試験市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。この市場を牽引しているのは、医薬品の臨床試験件数の増加、薬剤送達のための人工知能（AI）ベースのツールの採用増加、個別化医療と標的治療に対する需要の高まりです。
Technavioの米国臨床試験市場は以下のように区分される：
タイプ別
- フェーズIII
- フェーズI
- フェーズII
- フェーズIV
サービスタイプ別
- 介入研究
- 観察研究
- 拡張アクセス研究
適応症別
- がん領域
- 中枢神経系
- 自己免疫/炎症
- 心血管その他
本調査では、テクノロジーと科学研究の進歩が、今後数年間における米国の臨床試験市場の成長を牽引する主要因の一つであると指摘している。また、臨床試験プロセスのアウトソーシングの増加や医療・製薬産業への投資の増加は、市場の大きな需要につながる。
この調査レポートは、米国の臨床試験市場を調査・分析し、以下のてこ入れを行っています：
- 米国の臨床試験市場規模
- 米国の臨床試験市場予測
- 米国の臨床試験市場産業分析
本レポートでは、米国における臨床試験市場の主要ベンダー（Medpace Holdings Inc.、Laboratory Corp、ICON plc、Syneos Health Inc.、IQVIA Holdings Inc.、Charles River Laboratories International Inc.、Parexel International Corp.、Pfizer Inc.、Thermo Fisher Scientific Inc.、Caidya、Accell Clinical Research LLC、Clinipace Inc.、eResearchTechnology GmbH、Apex Medical Research Inc.、WuXi AppTec Co.Ltd.、Novartis AG、Novo Nordisk AS、Eli Lilly and Co.また、米国の臨床試験市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/us-clinical-trials-market-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Country Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Service Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Indication
o Exhibit 07: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 08: Parent market
o Exhibit 09: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 10: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 11: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 12: Chart on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 13: Data Table on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 14: Chart on US: Year-over-year growth 2022-2027 (%)
o Exhibit 15: Data Table on US: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Clinical trials market in US 2017 - 2021
o Exhibit 16: Historic Market Size - Data Table on clinical trials market in US 2017 - 2021 ($ billion)
o 4.2 Type Segment Analysis 2017 - 2021
o Exhibit 17: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
o 4.3 Service Type Segment Analysis 2017 - 2021
o Exhibit 18: Historic Market Size - Service Type Segment 2017 - 2021 ($ billion)
o 4.4 Indication Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Indication Segment 2017 - 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 20: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 21: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 22: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 23: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 24: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 25: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 26: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 27: Chart on Type - Market share 2022-2027 (%)
o Exhibit 28: Data Table on Type - Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 29: Chart on Comparison by Type
o Exhibit 30: Data Table on Comparison by Type
o 6.3 Phase III - Market size and forecast 2022-2027
o Exhibit 31: Chart on Phase III - Market size and forecast 2022-2027 ($ billion)
o Exhibit 32: Data Table on Phase III - Market size and forecast 2022-2027 ($ billion)
o Exhibit 33: Chart on Phase III - Year-over-year growth 2022-2027 (%)
o Exhibit 34: Data Table on Phase III - Year-over-year growth 2022-2027 (%)
o 6.4 Phase I - Market size and forecast 2022-2027
o Exhibit 35: Chart on Phase I - Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Data Table on Phase I - Market size and forecast 2022-2027 ($ billion)
o Exhibit 37: Chart on Phase I - Year-over-year growth 2022-2027 (%)
o Exhibit 38: Data Table on Phase I - Year-over-year growth 2022-2027 (%)
o 6.5 Phase II - Market size and forecast 2022-2027
o Exhibit 39: Chart on Phase II - Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Data Table on Phase II - Market size and forecast 2022-2027 ($ billion)
o Exhibit 41: Chart on Phase II - Year-over-year growth 2022-2027 (%)
o Exhibit 42: Data Table on Phase II - Year-over-year growth 2022-2027 (%)
o 6.6 Phase IV - Market size and forecast 2022-2027
o Exhibit 43: Chart on Phase IV - Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Data Table on Phase IV - Market size and forecast 2022-2027 ($ billion)
o Exhibit 45: Chart on Phase IV - Year-over-year growth 2022-2027 (%)
o Exhibit 46: Data Table on Phase IV - Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Type
o Exhibit 47: Market opportunity by Type ($ billion)
o Exhibit 48: Data Table on Market opportunity by Type ($ billion)
• 7 Market Segmentation by Service Type
o 7.1 Market segments
o Exhibit 49: Chart on Service Type - Market share 2022-2027 (%)
o Exhibit 50: Data Table on Service Type - Market share 2022-2027 (%)
o 7.2 Comparison by Service Type
o Exhibit 51: Chart on Comparison by Service Type
o Exhibit 52: Data Table on Comparison by Service Type
o 7.3 Interventional studies - Market size and forecast 2022-2027
o Exhibit 53: Chart on Interventional studies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 54: Data Table on Interventional studies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 55: Chart on Interventional studies - Year-over-year growth 2022-2027 (%)
o Exhibit 56: Data Table on Interventional studies - Year-over-year growth 2022-2027 (%)
o 7.4 Observational studies - Market size and forecast 2022-2027
o Exhibit 57: Chart on Observational studies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 58: Data Table on Observational studies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 59: Chart on Observational studies - Year-over-year growth 2022-2027 (%)
o Exhibit 60: Data Table on Observational studies - Year-over-year growth 2022-2027 (%)
o 7.5 Expanded access studies - Market size and forecast 2022-2027
o Exhibit 61: Chart on Expanded access studies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Data Table on Expanded access studies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 63: Chart on Expanded access studies - Year-over-year growth 2022-2027 (%)
o Exhibit 64: Data Table on Expanded access studies - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Service Type
o Exhibit 65: Market opportunity by Service Type ($ billion)
o Exhibit 66: Data Table on Market opportunity by Service Type ($ billion)
• 8 Market Segmentation by Indication
o 8.1 Market segments
o Exhibit 67: Chart on Indication - Market share 2022-2027 (%)
o Exhibit 68: Data Table on Indication - Market share 2022-2027 (%)
o 8.2 Comparison by Indication
o Exhibit 69: Chart on Comparison by Indication
o Exhibit 70: Data Table on Comparison by Indication
o 8.3 Oncology - Market size and forecast 2022-2027
o Exhibit 71: Chart on Oncology - Market size and forecast 2022-2027 ($ billion)
o Exhibit 72: Data Table on Oncology - Market size and forecast 2022-2027 ($ billion)
o Exhibit 73: Chart on Oncology - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
o 8.4 CNS - Market size and forecast 2022-2027
o Exhibit 75: Chart on CNS - Market size and forecast 2022-2027 ($ billion)
o Exhibit 76: Data Table on CNS - Market size and forecast 2022-2027 ($ billion)
o Exhibit 77: Chart on CNS - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on CNS - Year-over-year growth 2022-2027 (%)
o 8.5 Autoimmune/inflammation - Market size and forecast 2022-2027
o Exhibit 79: Chart on Autoimmune/inflammation - Market size and forecast 2022-2027 ($ billion)
o Exhibit 80: Data Table on Autoimmune/inflammation - Market size and forecast 2022-2027 ($ billion)
o Exhibit 81: Chart on Autoimmune/inflammation - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Autoimmune/inflammation - Year-over-year growth 2022-2027 (%)
o 8.6 Cardiovascular and others - Market size and forecast 2022-2027
o Exhibit 83: Chart on Cardiovascular and others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 84: Data Table on Cardiovascular and others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 85: Chart on Cardiovascular and others - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Cardiovascular and others - Year-over-year growth 2022-2027 (%)
o 8.7 Market opportunity by Indication
o Exhibit 87: Market opportunity by Indication ($ billion)
o Exhibit 88: Data Table on Market opportunity by Indication ($ billion)
• 9 Customer Landscape
o 9.1 Customer landscape overview
o Exhibit 89: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 90: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 91: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 92: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 93: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 94: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 95: Matrix on vendor position and classification
o 12.3 Accell Clinical Research LLC
o Exhibit 96: Accell Clinical Research LLC - Overview
o Exhibit 97: Accell Clinical Research LLC - Key offerings
o 12.4 Caidya
o Exhibit 98: Caidya - Overview
o Exhibit 99: Caidya - Key offerings
o 12.5 Charles River Laboratories International Inc.
o Exhibit 100: Charles River Laboratories International Inc. - Overview
o Exhibit 101: Charles River Laboratories International Inc. - Business segments
o Exhibit 102: Charles River Laboratories International Inc. - Key news
o Exhibit 103: Charles River Laboratories International Inc. - Key offerings
o Exhibit 104: Charles River Laboratories International Inc. - Segment focus
o 12.6 Clinipace Inc.
o Exhibit 105: Clinipace Inc. - Overview
o Exhibit 106: Clinipace Inc. - Product / Service
o Exhibit 107: Clinipace Inc. - Key offerings
o 12.7 CTI Clinical Trial and Consulting Inc.
o Exhibit 108: CTI Clinical Trial and Consulting Inc. - Overview
o Exhibit 109: CTI Clinical Trial and Consulting Inc. - Product / Service
o Exhibit 110: CTI Clinical Trial and Consulting Inc. - Key offerings
o 12.8 Eli Lilly and Co.
o Exhibit 111: Eli Lilly and Co. - Overview
o Exhibit 112: Eli Lilly and Co. - Product / Service
o Exhibit 113: Eli Lilly and Co. - Key news
o Exhibit 114: Eli Lilly and Co. - Key offerings
o 12.9 ICON plc
o Exhibit 115: ICON plc - Overview
o Exhibit 116: ICON plc - Product / Service
o Exhibit 117: ICON plc - Key offerings
o 12.10 IQVIA Holdings Inc.
o Exhibit 118: IQVIA Holdings Inc. - Overview
o Exhibit 119: IQVIA Holdings Inc. - Business segments
o Exhibit 120: IQVIA Holdings Inc. - Key news
o Exhibit 121: IQVIA Holdings Inc. - Key offerings
o Exhibit 122: IQVIA Holdings Inc. - Segment focus
o 12.11 Laboratory Corp. of America Holdings
o Exhibit 123: Laboratory Corp. of America Holdings - Overview
o Exhibit 124: Laboratory Corp. of America Holdings - Business segments
o Exhibit 125: Laboratory Corp. of America Holdings - Key news
o Exhibit 126: Laboratory Corp. of America Holdings - Key offerings
o Exhibit 127: Laboratory Corp. of America Holdings - Segment focus
o 12.12 Medpace Holdings Inc.
o Exhibit 128: Medpace Holdings Inc. - Overview
o Exhibit 129: Medpace Holdings Inc. - Product / Service
o Exhibit 130: Medpace Holdings Inc. - Key offerings
o 12.13 Parexel International Corp.
o Exhibit 131: Parexel International Corp. - Overview
o Exhibit 132: Parexel International Corp. - Product / Service
o Exhibit 133: Parexel International Corp. - Key news
o Exhibit 134: Parexel International Corp. - Key offerings
o 12.14 Pfizer Inc.
o Exhibit 135: Pfizer Inc. - Overview
o Exhibit 136: Pfizer Inc. - Product / Service
o Exhibit 137: Pfizer Inc. - Key news
o Exhibit 138: Pfizer Inc. - Key offerings
o 12.15 Sanofi
o Exhibit 139: Sanofi - Overview
o Exhibit 140: Sanofi - Business segments
o Exhibit 141: Sanofi - Key news
o Exhibit 142: Sanofi - Key offerings
o Exhibit 143: Sanofi - Segment focus
o 12.16 Syneos Health Inc.
o Exhibit 144: Syneos Health Inc. - Overview
o Exhibit 145: Syneos Health Inc. - Business segments
o Exhibit 146: Syneos Health Inc. - Key offerings
o Exhibit 147: Syneos Health Inc. - Segment focus
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 148: Thermo Fisher Scientific Inc. - Overview
o Exhibit 149: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 150: Thermo Fisher Scientific Inc. - Key news
o Exhibit 151: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 152: Thermo Fisher Scientific Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 153: Inclusions checklist
o Exhibit 154: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 155: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 156: Research methodology
o Exhibit 157: Validation techniques employed for market sizing
o Exhibit 158: Information sources
o 13.5 List of abbreviations
o Exhibit 159: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Country Market Characteristics
Exhibits4: Executive Summary - Chart on Market Segmentation by Type
Exhibits5: Executive Summary - Chart on Market Segmentation by Service Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Indication
Exhibits7: Executive Summary - Chart on Vendor Market Positioning
Exhibits8: Parent market
Exhibits9: Market Characteristics
Exhibits10: Offerings of vendors included in the market definition
Exhibits11: Market segments
Exhibits12: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits13: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits14: Chart on US: Year-over-year growth 2022-2027 (%)
Exhibits15: Data Table on US: Year-over-year growth 2022-2027 (%)
Exhibits16: Historic Market Size - Data Table on clinical trials market in US 2017 - 2021 ($ billion)
Exhibits17: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
Exhibits18: Historic Market Size - Service Type Segment 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Indication Segment 2017 - 2021 ($ billion)
Exhibits20: Five forces analysis - Comparison between 2022 and 2027
Exhibits21: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits22: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits23: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits24: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits25: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits26: Chart on Market condition - Five forces 2022 and 2027
Exhibits27: Chart on Type - Market share 2022-2027 (%)
Exhibits28: Data Table on Type - Market share 2022-2027 (%)
Exhibits29: Chart on Comparison by Type
Exhibits30: Data Table on Comparison by Type
Exhibits31: Chart on Phase III - Market size and forecast 2022-2027 ($ billion)
Exhibits32: Data Table on Phase III - Market size and forecast 2022-2027 ($ billion)
Exhibits33: Chart on Phase III - Year-over-year growth 2022-2027 (%)
Exhibits34: Data Table on Phase III - Year-over-year growth 2022-2027 (%)
Exhibits35: Chart on Phase I - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Data Table on Phase I - Market size and forecast 2022-2027 ($ billion)
Exhibits37: Chart on Phase I - Year-over-year growth 2022-2027 (%)
Exhibits38: Data Table on Phase I - Year-over-year growth 2022-2027 (%)
Exhibits39: Chart on Phase II - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Data Table on Phase II - Market size and forecast 2022-2027 ($ billion)
Exhibits41: Chart on Phase II - Year-over-year growth 2022-2027 (%)
Exhibits42: Data Table on Phase II - Year-over-year growth 2022-2027 (%)
Exhibits43: Chart on Phase IV - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Data Table on Phase IV - Market size and forecast 2022-2027 ($ billion)
Exhibits45: Chart on Phase IV - Year-over-year growth 2022-2027 (%)
Exhibits46: Data Table on Phase IV - Year-over-year growth 2022-2027 (%)
Exhibits47: Market opportunity by Type ($ billion)
Exhibits48: Data Table on Market opportunity by Type ($ billion)
Exhibits49: Chart on Service Type - Market share 2022-2027 (%)
Exhibits50: Data Table on Service Type - Market share 2022-2027 (%)
Exhibits51: Chart on Comparison by Service Type
Exhibits52: Data Table on Comparison by Service Type
Exhibits53: Chart on Interventional studies - Market size and forecast 2022-2027 ($ billion)
Exhibits54: Data Table on Interventional studies - Market size and forecast 2022-2027 ($ billion)
Exhibits55: Chart on Interventional studies - Year-over-year growth 2022-2027 (%)
Exhibits56: Data Table on Interventional studies - Year-over-year growth 2022-2027 (%)
Exhibits57: Chart on Observational studies - Market size and forecast 2022-2027 ($ billion)
Exhibits58: Data Table on Observational studies - Market size and forecast 2022-2027 ($ billion)
Exhibits59: Chart on Observational studies - Year-over-year growth 2022-2027 (%)
Exhibits60: Data Table on Observational studies - Year-over-year growth 2022-2027 (%)
Exhibits61: Chart on Expanded access studies - Market size and forecast 2022-2027 ($ billion)
Exhibits62: Data Table on Expanded access studies - Market size and forecast 2022-2027 ($ billion)
Exhibits63: Chart on Expanded access studies - Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on Expanded access studies - Year-over-year growth 2022-2027 (%)
Exhibits65: Market opportunity by Service Type ($ billion)
Exhibits66: Data Table on Market opportunity by Service Type ($ billion)
Exhibits67: Chart on Indication - Market share 2022-2027 (%)
Exhibits68: Data Table on Indication - Market share 2022-2027 (%)
Exhibits69: Chart on Comparison by Indication
Exhibits70: Data Table on Comparison by Indication
Exhibits71: Chart on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibits72: Data Table on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibits73: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on CNS - Market size and forecast 2022-2027 ($ billion)
Exhibits76: Data Table on CNS - Market size and forecast 2022-2027 ($ billion)
Exhibits77: Chart on CNS - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on CNS - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Autoimmune/inflammation - Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on Autoimmune/inflammation - Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on Autoimmune/inflammation - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Autoimmune/inflammation - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Cardiovascular and others - Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on Cardiovascular and others - Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on Cardiovascular and others - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Cardiovascular and others - Year-over-year growth 2022-2027 (%)
Exhibits87: Market opportunity by Indication ($ billion)
Exhibits88: Data Table on Market opportunity by Indication ($ billion)
Exhibits89: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits90: Impact of drivers and challenges in 2022 and 2027
Exhibits91: Overview on Criticality of inputs and Factors of differentiation
Exhibits92: Overview on factors of disruption
Exhibits93: Impact of key risks on business
Exhibits94: Vendors covered
Exhibits95: Matrix on vendor position and classification
Exhibits96: Accell Clinical Research LLC - Overview
Exhibits97: Accell Clinical Research LLC - Key offerings
Exhibits98: Caidya - Overview
Exhibits99: Caidya - Key offerings
Exhibits100: Charles River Laboratories International Inc. - Overview
Exhibits101: Charles River Laboratories International Inc. - Business segments
Exhibits102: Charles River Laboratories International Inc. - Key news
Exhibits103: Charles River Laboratories International Inc. - Key offerings
Exhibits104: Charles River Laboratories International Inc. - Segment focus
Exhibits105: Clinipace Inc. - Overview
Exhibits106: Clinipace Inc. - Product / Service
Exhibits107: Clinipace Inc. - Key offerings
Exhibits108: CTI Clinical Trial and Consulting Inc. - Overview
Exhibits109: CTI Clinical Trial and Consulting Inc. - Product / Service
Exhibits110: CTI Clinical Trial and Consulting Inc. - Key offerings
Exhibits111: Eli Lilly and Co. - Overview
Exhibits112: Eli Lilly and Co. - Product / Service
Exhibits113: Eli Lilly and Co. - Key news
Exhibits114: Eli Lilly and Co. - Key offerings
Exhibits115: ICON plc - Overview
Exhibits116: ICON plc - Product / Service
Exhibits117: ICON plc - Key offerings
Exhibits118: IQVIA Holdings Inc. - Overview
Exhibits119: IQVIA Holdings Inc. - Business segments
Exhibits120: IQVIA Holdings Inc. - Key news
Exhibits121: IQVIA Holdings Inc. - Key offerings
Exhibits122: IQVIA Holdings Inc. - Segment focus
Exhibits123: Laboratory Corp. of America Holdings - Overview
Exhibits124: Laboratory Corp. of America Holdings - Business segments
Exhibits125: Laboratory Corp. of America Holdings - Key news
Exhibits126: Laboratory Corp. of America Holdings - Key offerings
Exhibits127: Laboratory Corp. of America Holdings - Segment focus
Exhibits128: Medpace Holdings Inc. - Overview
Exhibits129: Medpace Holdings Inc. - Product / Service
Exhibits130: Medpace Holdings Inc. - Key offerings
Exhibits131: Parexel International Corp. - Overview
Exhibits132: Parexel International Corp. - Product / Service
Exhibits133: Parexel International Corp. - Key news
Exhibits134: Parexel International Corp. - Key offerings
Exhibits135: Pfizer Inc. - Overview
Exhibits136: Pfizer Inc. - Product / Service
Exhibits137: Pfizer Inc. - Key news
Exhibits138: Pfizer Inc. - Key offerings
Exhibits139: Sanofi - Overview
Exhibits140: Sanofi - Business segments
Exhibits141: Sanofi - Key news
Exhibits142: Sanofi - Key offerings
Exhibits143: Sanofi - Segment focus
Exhibits144: Syneos Health Inc. - Overview
Exhibits145: Syneos Health Inc. - Business segments
Exhibits146: Syneos Health Inc. - Key offerings
Exhibits147: Syneos Health Inc. - Segment focus
Exhibits148: Thermo Fisher Scientific Inc. - Overview
Exhibits149: Thermo Fisher Scientific Inc. - Business segments
Exhibits150: Thermo Fisher Scientific Inc. - Key news
Exhibits151: Thermo Fisher Scientific Inc. - Key offerings
Exhibits152: Thermo Fisher Scientific Inc. - Segment focus
Exhibits153: Inclusions checklist
Exhibits154: Exclusions checklist
Exhibits155: Currency conversion rates for US$
Exhibits156: Research methodology
Exhibits157: Validation techniques employed for market sizing
Exhibits158: Information sources
Exhibits159: List of abbreviations